Our prior work using a panel of six TAAs (i.e., p53, NY-ESO-1, MMP-7, Hsp70, PRDX, and Bmi-1) to assess the early-stage ESCC detection obtained a sensitivity and specificity of 45% and 95%, respectively [22]. This evidence concerns the gene BMI1 and esophageal squamous cell carcinoma.